Aptera Q3 10-Q: $35.0M Nine-Month Loss, $9.2M Cash, Going Concern Doubt Unresolved
SEV sits 23% above its 52-week low of $1.29.
Summary
Aptera's Q3 10-Q shows a $35.0 million nine-month net loss, $9.2 million of cash (including $4.1 million of refundable reservation fees), and going concern doubt that management says has not been alleviated. The company still needs about $25 million to reach start of production and is funding itself through discounted equity sales and warrant exercises.
Key Events · Earnings and Guidance · SEV
-
Q3 Loss Widens, Cash Down to $9.2M
Q3 2026 net loss was $14.0 million versus $5.5 million a year earlier; nine-month net loss reached $35.0 million versus $28.4 million. Cash and equivalents were $9.2 million at September 30, 2026, including $4.1 million of refundable reservation fees.
-
Going Concern Doubt Not Alleviated
Management states existing cash is not sufficient to fund operations for the next twelve months and that substantial doubt about going concern has not been alleviated, because the plan depends on raising capital on acceptable terms.
-
Cash Burn Outpaces Financing
Nine-month operating cash use was $23.3 million versus $10.9 million a year earlier, driven by $4.5 million more outside consulting for vehicle build and testing and $3.0 million more engineering personnel cost. Financing brought in $23.1 million, leaving cash down $0.4 million for the period.
-
Discounted Raise and 50% Participation Right
The November 10, 2026 registered direct sold 3,428,571 shares at $1.75 plus 3,428,571 warrants at $2.05 for $6.0 million gross, closing November 12. Those investors can buy up to 50% of any future financing until November 12, 2027.
Analysis · SEV · Manufacturing
Aptera burned $23.3 million of operating cash in nine months and ended September with $9.2 million — of which $4.1 million is refundable customer reservation money, not operating capital. Management states plainly that existing cash will not fund the next twelve months and that substantial doubt about going concern has not been alleviated, so survival now hinges on selling stock: the ELOC ($69.7 million left but capped at 5,471,846 total shares), a $19.0 million ATM whose prospectus was already terminated on November 9, and warrant exercises. The November 10 registered direct raised only $6.0 million at $1.75 — a 23% discount to the $2.28 last sale — and handed those investors a right to buy up to 50% of any future financing until November 12, 2027, which will make the next raise harder and more expensive. Against that, the company cut its estimate to reach start of production to about $25 million from $40-45 million, so the gap is narrower than it was, but it is still roughly 2.7x the cash on hand. Both previously disclosed material weaknesses in internal control remain unremediated and the SEC subpoena from January 2025 is still open.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SEV was trading at $1.59 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $64.3M. The 52-week trading range was $1.29 to $7.99. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.